
Public health and research
Cheap HIV drugs for Africa
In 2001 the Indian drug company Cipla offered a three-drug HIV combination at about $350 per patient a year, a small fraction of Western prices. Price cuts followed, and treatment reached millions in Africa.
Why it matters
It showed that treatment could be cheap, and helped start mass treatment in poor countries.
People: Yusuf Hamied
Builds on: Combination drugs hold HIV back